Histatins: antimicrobial peptides with therapeutic potential

Area of Science:

• Biochemistry
• Microbiology
• Oral Medicine

Background:

• Histatins are salivary antimicrobial peptides with known antifungal properties.
• Conventional antifungal drugs like azoles and polyenes face challenges with drug resistance.
• Fungal infections, particularly in the oral cavity, require novel therapeutic approaches.

Purpose of the Study:

• To investigate the mechanism of action of histatins against fungal pathogens.
• To evaluate the potential of histatins as therapeutic agents for oral fungal infections.
• To assess the clinical efficacy and safety of histatin-based preparations.

Main Methods:

• Analysis of histatin interaction with fungal cell membranes and mitochondria.
• Assessment of ATP depletion, cell cycle disruption, and reactive oxygen species generation.
• Clinical evaluation of topical histatin preparations and histatin-impregnated denture acrylic.

Main Results:

• Histatins induce non-lytic ATP loss and cell death by targeting fungal mitochondria.
• Histatins disrupt the fungal cell cycle and generate reactive oxygen species.
• Clinical studies show histatin preparations are safe and effective in preventing Candida albicans adherence, reducing plaque, and improving gingivitis.

Conclusions:

• Histatins possess a unique mode of action distinct from conventional antifungals.
• Histatins represent a novel class of antimicrobial compounds for treating oral fungal infections.
• Histatin preparations demonstrate safety and efficacy, offering a promising alternative for managing drug-resistant fungal infections.